A carregar...
Synchronous Presence of EGFR, ALK Driver Mutations Along With PD L1 Overexpression in a Resected Early Stage Non-Small Cell Lung Cancer: A Case Report and Review of Literature
Treatment of lung cancer has been revolutionized with development of drugs that target key driver mutations and immune checkpoints. Until recently, it was believed that these driver mutations are mutually exclusive. However, few reports have emerged citing the presence of both mutations either synch...
Na minha lista:
Publicado no: | World J Oncol |
---|---|
Main Authors: | , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Elmer Press
2018
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5942208/ https://ncbi.nlm.nih.gov/pubmed/29760833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/wjon1090e |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|